Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Intersect ENT CEO Lisa Earnhardt Discusses New Products and Plans as Medtech Talk Hits the 100 Mark

April 11, 2018

CEO Lisa Earnhardt, who appeared as the first guest on the Medtech Talk Podcast, returns in episode number 100 to share why she took the helm of the 12-person start-up 10 years ago, and how Intersect ENT has managed company culture over years of enormous growth. She also discusses where Intersect ENT is headed in the future, with new products and business development projects.

Lisa Earnhardt

President & CEO

Intersect ENT

Lisa Earnhardt leads Intersect ENT (NASDAQ: XENT), a medical technology company dedicated to improving the quality of life for patients with ear, nose and throat conditions. She has led the company from 12 employees through the clinical stage, FDA approval, commercialization, IPO, to 2017 revenue of $96M and over 350 employees. Previously, she was President of Boston Scientific’s Cardiac Surgery division. Lisa has over two decades of experience in healthcare, primarily in leading global product launches and driving adoption of new medical technologies at both Boston Scientific and Guidant. She began her career at APM/CSC Healthcare where she provided management consulting services to healthcare provider organizations. Lisa serves on the boards of Intersect ENT and Nevro Corporation (NYSE: NVRO), a medical device company with a disruptive technology for treating chronic pain and other neuro disorders. She is a former Director of Kensey Nash (NASDAQ: KNSY, acquired by DSM in 2012). Lisa is a member of the board of directors of AdvaMed (Advanced Medical Technology Association) and the Kellogg Global Advisory Board. She received a Bachelor of Science in industrial engineering from Stanford University and an MBA from the Kellogg Graduate School of Management at Northwestern University.